TG and hypothyroidism: The HAART therapy, which improves HIV prognosis, also affects the metabolism of thyroid hormone, though its impact on hypothyroidism remains controversial and inconsistent, while high levels of FT3, subclinical hyperthyroidism and GD have been reported (Beltran et al., 2003).